What is LeMaitre Vascular's R&D?

LeMaitre Vascular (LMAT) reported R&D of $4.06M in Q1 2026.

How has LeMaitre Vascular's R&D changed year-over-year?

LeMaitre Vascular's R&D decreased by 0.9% year-over-year, from $4.1M to $4.06M.

What is the long-term trend for LeMaitre Vascular's R&D?

Over 4 years (2021 to 2025), LeMaitre Vascular's R&D has grown at a 4.6% compound annual growth rate (CAGR), from $11.8M to $14.14M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

LeMaitre Vascular LMAT R&D

R&D at other companies

ITG

Integer HoldingsITGR

$16.24M+14.4%

Merit Medical SystemsMMSI

$22.61M+0.6%

HaemoneticsHAE

$14.45M-21.1%

AbbottABT

$767M+7.1%

Baxter InternationalBAX

$139M-0.7%

Becton, Dickinson and CompanyBDX

$249M+7.3%

Other financials

Income statement

See full

Revenue$66.6M+11.2%

Gross profit$48.4M+16.8%

Operating income$17.8M+40.8%

Net income$15.7M+42.4%

EPS (diluted)$0.68+41.7%

Balance sheet

See full

Cash & equivalents$26.9M+6.0%

Total debt$20.9M+20.6%

Total equity$406.6M+17.0%

Total assets$629.5M+13.2%

Cash flow

See full

Operating cash flow$15.1M+67.0%

CapEx$2.8M+101%

Free cash flow$12.3M+60.8%

Valuation

See full

Market cap$2.1B+31.4%

Enterprise value$2.1B+31.6%

P/E33.7×-1.7×

P/S8.2×+1.1×

Profitability

See full

Gross margin72.4%+3.6pp

Operating margin28.5%+5.1pp

Net margin24.3%+4.4pp

FCF margin30.9%+12.7pp

Returns & leverage

See full

Return on equity16.5%+2.8pp

Debt / equity0.1×0.0×

Current ratio14.3×-2.2×

Where this comes from

Reported directly by LeMaitre Vascular in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: LeMaitre Vascular’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LeMaitre Vascular's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is LeMaitre Vascular's R&D?: LeMaitre Vascular (LMAT) reported R&D of $4.06M in Q1 2026.
How has LeMaitre Vascular's R&D changed year-over-year?: LeMaitre Vascular's R&D decreased by 0.9% year-over-year, from $4.1M to $4.06M.
What is the long-term trend for LeMaitre Vascular's R&D?: Over 4 years (2021 to 2025), LeMaitre Vascular's R&D has grown at a 4.6% compound annual growth rate (CAGR), from $11.8M to $14.14M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.